August 17 | 12:00 pm – 1:00 pm EDT

Biotech’s lab of the future can’t wait! The potential to actualize a lab of the future is possible today with advances in technology, automation, robotics, and digitalization. These advances are reshaping how scientists run R&D labs, conduct experiments, share data and make decisions. However, legacy infrastructure and disconnected solutions are creating barriers that prevent achieving the promise of a lab of the future.

Lab of the future requires a modern, connected, adaptable solution that manages work traditionally done in siloed – and now outdated – ELN and LIMS solutions. With a shared solution connecting R&D data, teams can manage samples and processes with seamless handoffs and complete traceability. Join us for an engaging discussion with Dan Chapman, Director of the Experiment Design and Execution Platform Product at Merck, and experts from Zifo and Benchling.
In this webinar, we’ll discuss:

  • The challenges with legacy systems for today’s advanced biomolecules
  • Advantages of a modern LIMS
  • How to choose the right modern LIMS
  • Strategies to drive effective change management and adoption

Click here for additional details and registration information.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.